HIPRA | HIPRADOG 7 vaccine canine parvovirus for dogs

The information contained on this global HIPRA website is not intended for audiences in all countries.

General, scientific or technical information about HIPRA products or services is not intended for commercial promotion.

For specific information on the products or services available in your country, please filter by the corresponding country.

Select your country

Vaccines

Dogs

HIPRADOG 7

Live vaccine against canine parvovirus infections, distemper, hepatitis, laryngotracheitis and tracheobronchitis, in injectable freeze-dried tablet, and inactivated vaccine against canine leptospirosis, in injectable suspension.

View product data sheet

Related Publications

Last News

Discover our latest news

HIPRADOG 7

Canine distemper

Canine Leishmaniasis

Infectious canine hepatitis

Canine infectious tracheobronchitis

Canine parvovirus

Canine infectious laryngotracheitis

Canine leptospirosis

Related Publications

Antibody response against Canine Parvovirus of client-owned puppies after vaccination with bivalent vaccines

Is it possible to develop a protective response through vaccination against the different variants of parvovirus?

Antibody response against canine parvovirus of client-owned dog puppies after vaccination with bivalent or multivalent vaccines containing live attenuated strains

Reduction of canine leptospirosis disease and shedding by a leptospira bivalent vaccine following challenge in dogs

Last news

HIPRADOG® and YURVAC RHD present at WSAVA Companion Animal Congress

HIPRA participates in the WSAVA World Congress for the first time

HIPRA opts for eco-friendly packaging for all its monodose animal health vaccines

Switch off the non-rational use of antibiotics

We have evolved to be stronger

HIPRA participates in the 2020 CVDL & CVDC virtual congresses

Companion animal veterinarians from Spain visit HIPRA

CIVTEST® CANIS LEISHMANIA reaches Brazil

HIPRADOG 7

Related services

Related Diseases

Related Publications

Last news